Sees FY24 revenue at least $366B, consensus $345.81B. Sees FY24 adjusted operating income at least $17.2B. CVS Health interim CFO Tom Cowhey will detail the company’s 2024 financial outlook, capital deployment strategy, and long-term outlook and growth targets. The company said, “The company’s unique combination of assets provides CVS Health with clear opportunities for long-term outperformance, including through Medicare Advantage margin recovery, incorporating Star Ratings, starting in 2025; CVS CostVantage, the company’s new retail pharmacy pricing model; increased patient enrollment in Oak Street Health; expanded product offerings through Signify Health; and enhanced growth in core businesses from new offerings in health care delivery.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVS:
- CVS Health highlights path to accelerating long-term growth through building a world of health around every consumer
- CVS Health to hold investor day
- 3 Best Stocks to Buy Now, 11/22/2023, According to Top Analysts
- Foot Locker, Teamsters drop drug-benefit managers over costs, WSJ says
- Pharmageddon Post-Mortem: CVS (NYSE:CVS), Walgreens (NASDAQ:WBA) Unconcerned